ACE and myocardial infarction: The medication characteristics of periprocedural myocardial infarction patients were reflected in a higher proportion of use of angiotensin converting enzyme inhibitor/angiotensin receptor antagonist (ACEI/ARB), beta-blockers, calcium channel blockers (CCB) (all P values < 0.05).